CLINICAL_TRIALS
trial_result
· 2015-04-21
Clinical Trial Update: Alefacept for Prevention of Graft Versus Host Disease (GVHD) [Phase 3]
Summary
Phase 3 clinical trial evaluating alefacept to prevent graft-versus-host disease was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hadassah Medical Organization | Conditions: Graft Versus Host Disease | Phase 3 | Status: TERMINATED